CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioPharma Dive
Original article

J&J earnings set ‘negative tone’; Shkreli vs. the FTC

EarningsnegativeNegative
AI Analysis

Summary

J&J shares fell 6% following earnings results, reflecting broader market volatility. Gilead announced a collaboration with Vir Biotechnology.

Outcome Details

6% sell-off in J&J shares

Importance:3/10
Sentiment:
-0.60
earningsmarket_volatilitypartnershipcollaboration
Related Companies

Read the original article

Published by BioPharma Dive on October 14, 2026 1:31 PM

Read Original